Review of Fetocides at Chris Hani Baragwanath Academic Hospital Over a Three-Year Period

dc.contributor.authorKiaka, Gabin Munkita
dc.contributor.supervisorJeebodh, Jayshree
dc.date.accessioned2026-02-09T09:10:52Z
dc.date.issued2025
dc.descriptionA research report submitted in fulfillment of the requirements for the Master of Medicine, in the Faculty of Health Sciences, School of Medicine, University of the Witwatersrand, Johannesburg, 2025
dc.description.abstractBackground: Fetocide is necessary where termination of pregnancy is indicated after 24 weeks. Not many studies have been done particularly in a South African context. It is still regarded as a controversial issue in some countries. An earlier diagnosis allows more time for the counselling of parents and decision-making. • Objectives: To establish the demographics of patients offered fetocides procedures and the indications. To determine the gestational age at which the fetocides were performed at the Chris Hani Baragwanath Academic Hospital and the techniques (routes) used. • Methods: Retrospective cross-sectional study of 58 patients who underwent fetocide procedure for severe congenital anomalies at the Chris Hani Baragwanath Academic Hospital Feto maternal Unit. Means with standard deviations (SD) and medians with centiles were used for the continuous variables such as patients’ demographics. Frequencies and percentages were used for categorical and dichotomous variables. The chi-square test or Fisher ‘exact test were used in the descriptive analysis. The data were transferred into the STATA program for analysis. • Results: Fifty-eight patients underwent fetocide procedure. Fifteen percent Potassium chloride was the only agent used. The median age was 30 years (IQR=22-35), the median Body Mass Index (BMI) was 24 kg/m2, the median Gestational Age (GA) was 29 weeks (IQR=26-32). The umbilical vein route was used in 55% of mothers and the median Potassium Chloride volume used was 20 ml. Central Nervous System anomalies were the leading indication and anencephaly the leading anomaly. A total of 25(66%) fetuses had a normal karyotype result and 13(34%) of the 38 patients who had karyotype had an abnormal karyotype result. • Conclusion: Fetocides are a safe and effective method to induce fetal demise. Central Nervous System anomalies were the most common with anencephaly the leading one. There was an increasing risk of congenital anomalies with advanced maternal age, particularly above 35 years old. The umbilical vein route was the preferred route used. Further research is needed to explore especially the ethical implications for both the mother and the health care worker.
dc.description.submitterMM2026
dc.facultyFaculty of Health Sciences
dc.identifier.citationKiaka, Gabin Munkita. (2025). Review of Fetocides at Chris Hani Baragwanath Academic Hospital Over a Three-Year Period [Master`s dissertation, University of the Witwatersrand, Johannesburg]. WIReDSpace. https://hdl.handle.net/10539/47999
dc.identifier.urihttps://hdl.handle.net/10539/47999
dc.language.isoen
dc.publisherUniversity of the Witwatersrand, Johannesburg
dc.rights© 2025 University of the Witwatersrand, Johannesburg. All rights reserved. The copyright in this work vests in the University of the Witwatersrand, Johannesburg. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of University of the Witwatersrand, Johannesburg.
dc.rights.holderUniversity of the Witwatersrand, Johannesburg
dc.schoolSchool of Clinical Medicine
dc.subjectUCTD
dc.subjectFetus
dc.subjectfetocide
dc.subjectstructural congenital anomalies
dc.subject.primarysdgSDG-3: Good health and well-being
dc.titleReview of Fetocides at Chris Hani Baragwanath Academic Hospital Over a Three-Year Period
dc.typeDissertation

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Kiaka_Review_2025.pdf
Size:
1.76 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.43 KB
Format:
Item-specific license agreed upon to submission
Description: